Malfin

Morphine sulfate, the active ingredient in Malfin, is an opioid analgesic presented as an oral dosage form for oral use. It provides analgesia for moderate to severe acute and chronic pain in adult patients.

GNH USA supplies Malfin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine sulfate acts on the central nervous system to relieve pain of varying origins. - Acute pain: delivers rapid analgesia to reduce pain intensity after injury or surgery. - Chronic pain: offers sustained relief for long‑term conditions such as musculoskeletal disorders. - Post‑operative pain: helps manage pain following surgical procedures. - Cancer‑related pain: alleviates severe pain associated with malignant disease.

Morphine sulfate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: feeling of sickness or urge to vomit. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness. - Dry mouth: reduced salivation. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Addiction or dependence: potential for misuse and withdrawal. - Anaphylaxis: rare severe allergic reaction. - Adrenal insufficiency: impaired cortisol production. - Seizures: uncommon but possible neurological events.

When prescribing or dispensing morphine sulfate, several safety measures should be observed. - Assess pain severity and patient history: ensure appropriate indication before initiating therapy. - Monitor respiratory function: watch for signs of depression, especially during dose titration. - Avoid use in patients with severe respiratory insufficiency: risk of fatal respiratory depression. - Use caution in renal or hepatic impairment: altered drug clearance may require dose adjustment. - Consider tapering when discontinuing: to minimize withdrawal symptoms. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Morphine sulfate can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Benzodiazepines or other CNS depressants: additive respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increased plasma concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced analgesic effect. - Diuretics: may enhance hypotensive response. - Anticholinergic agents: can worsen constipation. - Serotonergic drugs: potential for serotonin syndrome. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal bleeding.